Microphysiological Systems

Researchers are developing and utilizing microphysiological systems, also known as organ-on-a-chip technology, to model human organ function and disease. These systems involve creating miniature devices that replicate the biological and mechanical functions of human organs, such as the heart, lungs, and liver, on a microfluidic chip. This work aims to understand complex biological processes, screen potential drug candidates, and assess the toxicological effects of various substances in a more physiologically relevant manner than traditional cell cultures or animal models. Research encompasses the engineering of these devices, the incorporation of living cells, and the development of analytical techniques to measure system responses.

This research holds particular relevance for Arkansas's public health initiatives and its growing biosciences sector. By providing more accurate models for drug testing and toxicity assessment, these systems can aid in the development of safer pharmaceuticals and consumer products, potentially benefiting the health of Arkansans and supporting economic development in areas related to healthcare and biotechnology. Furthermore, understanding how environmental factors or dietary components affect organ function through these advanced models could inform public health strategies relevant to the state's demographics and prevalent health concerns.

This area of study draws on expertise from engineering, biology, and toxicology. It connects to broader research efforts in cardiovascular health, pharmacological studies, disease mechanisms, and metabolic disorders, fostering interdisciplinary collaboration across institutions within Arkansas.